These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 26005932
21. Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin. Cong Y, Quan C, Liu M, Liu J, Huang G, Tong G, Yin Y, Zhang C, Jiang Q. J Biomater Sci Polym Ed; 2015; 26(11):629-43. PubMed ID: 25994241 [Abstract] [Full Text] [Related]
23. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro. Wang Y, Guo M, Lu Y, Ding LY, Ron WT, Liu YQ, Song FF, Yu SQ. Nanotechnology; 2012 Dec 14; 23(49):495103. PubMed ID: 23149859 [Abstract] [Full Text] [Related]
24. Antibacterial activity of poly(vinyl alcohol)-b-poly(acrylonitrile) based micelles loaded with silver nanoparticles. Bryaskova R, Pencheva D, Kyulavska M, Bozukova D, Debuigne A, Detrembleur C. J Colloid Interface Sci; 2010 Apr 15; 344(2):424-8. PubMed ID: 20074742 [Abstract] [Full Text] [Related]
25. [In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,866 clinical isolates obtained from 72 centers in 2010]. Yamaguchi K, Ohno A, Ishii Y, Tateda K, Iwata M, Levofloxacin-Surveillance Group. Jpn J Antibiot; 2012 Jun 15; 65(3):181-206. PubMed ID: 23173294 [Abstract] [Full Text] [Related]
26. Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility. Kam KM, Yip CW, Cheung TL, Tang HS, Leung OC, Chan MY. Microb Drug Resist; 2006 Jun 15; 12(1):7-11. PubMed ID: 16584301 [Abstract] [Full Text] [Related]
27. [The history of the development and changes of quinolone antibacterial agents]. Takahashi H, Hayakawa I, Akimoto T. Yakushigaku Zasshi; 2003 Jun 15; 38(2):161-79. PubMed ID: 15143768 [Abstract] [Full Text] [Related]
28. Cerium oxide nanoparticles as potential antibiotic adjuvant. Effects of CeO2 nanoparticles on bacterial outer membrane permeability. Bellio P, Luzi C, Mancini A, Cracchiolo S, Passacantando M, Di Pietro L, Perilli M, Amicosante G, Santucci S, Celenza G. Biochim Biophys Acta Biomembr; 2018 Nov 15; 1860(11):2428-2435. PubMed ID: 30026034 [Abstract] [Full Text] [Related]
29. Antimicrobial activity of a new synthetic peptide loaded in polylactic acid or poly(lactic-co-glycolic) acid nanoparticles against Pseudomonas aeruginosa, Escherichia coli O157:H7 and methicillin resistant Staphylococcus aureus (MRSA). Cruz J, Flórez J, Torres R, Urquiza M, Gutiérrez JA, Guzmán F, Ortiz CC. Nanotechnology; 2017 Mar 01; 28(13):135102. PubMed ID: 28266350 [Abstract] [Full Text] [Related]
30. Antibacterial modification of an injectable, biodegradable, non-cytotoxic block copolymer-based physical gel with body temperature-stimulated sol-gel transition and controlled drug release. Wang X, Hu H, Wang W, Lee KI, Gao C, He L, Wang Y, Lai C, Fei B, Xin JH. Colloids Surf B Biointerfaces; 2016 Jul 01; 143():342-351. PubMed ID: 27022875 [Abstract] [Full Text] [Related]
31. Ofloxacin minimum inhibitory concentration versus disk diffusion zone diameter for Salmonella enterica serovar Typhi isolates: problems in the detection of ofloxacin resistance. Mandal S, Mandal MD, Pal NK. Jpn J Infect Dis; 2003 Jul 01; 56(5-6):210-2. PubMed ID: 14695432 [Abstract] [Full Text] [Related]
32. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity. Jeong YI, Na HS, Seo DH, Kim DG, Lee HC, Jang MK, Na SK, Roh SH, Kim SI, Nah JW. Int J Pharm; 2008 Mar 20; 352(1-2):317-23. PubMed ID: 18160236 [Abstract] [Full Text] [Related]
33. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo. Yao Q, Wang J, Cui T, Yang Z, Su M, Zhao P, Yan H, Zhan Y, Yang H. Molecules; 2016 Jan 06; 21(1):62. PubMed ID: 26751436 [Abstract] [Full Text] [Related]
34. [Susceptibilities of clinical isolates to antibacterial agents. A study mainly focused on ofloxacin (the second report). Reported by the Research Group for Testing ofloxacin Susceptibility on Clinical Isolates]. Kosakai N. Jpn J Antibiot; 1989 May 06; 42(5):1125-65. PubMed ID: 2664255 [Abstract] [Full Text] [Related]
35. Sensitivity of bacteria to diamond nanoparticles of various size differs in gram-positive and gram-negative cells. Beranová J, Seydlová G, Kozak H, Benada O, Fišer R, Artemenko A, Konopásek I, Kromka A. FEMS Microbiol Lett; 2014 Feb 06; 351(2):179-86. PubMed ID: 24386940 [Abstract] [Full Text] [Related]
36. Folic acid-modified mesoporous silica nanoparticles with pH-responsiveness loaded with Amp for an enhanced effect against anti-drug-resistant bacteria by overcoming efflux pump systems. Chen X, Liu Y, Lin A, Huang N, Long L, Gang Y, Liu J. Biomater Sci; 2018 Jun 25; 6(7):1923-1935. PubMed ID: 29850668 [Abstract] [Full Text] [Related]
37. In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles. Feczkó T, Fodor-Kardos A, Sivakumaran M, Haque Shubhra QT. Nanomedicine (Lond); 2016 Aug 25; 11(16):2029-34. PubMed ID: 27462975 [Abstract] [Full Text] [Related]